Maintaining a consistent weekly injection schedule is critical for sustained results
Incretin therapies The first generation of weight-loss medications are incretin therapies that regulate insulin secretion, building on type 2 diabetes mellitus (T2DM) treatments utilising glucagon-like peptide-1 (GLP-1) receptor agonists
Eligibility depends on several factors, including BMI, medical history, current medications, side effect risks, and insurance rules
Severe abdominal pain, particularly if it is persistent and located in the upper abdomen radiating to the back, requires urgent assessment to exclude pancreatitis, a rare but serious adverse effect of GLP-1 receptor agonists identified in the Wegovy SmPC
Will my arm lift scars be noticeable
doi: 10.1073/pnas.0700440104 106 MayorgasADottiISalasA